
A modified poliovirus therapy that is showing promising results for patients with glioblastoma brain tumors works best at a low dosage, according to the research team where the investigational therapy is being pioneered.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/JP_sC5_NiFM/150601092103.htm